Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.21 USD | +2.99% | +7.90% | -9.90% |
08/05 | Transcript : Arcus Biosciences, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Earnings Flash (RCUS) ARCUS BIOSCIENCES Posts Q1 Revenue $145M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.90% | 156.53Cr | |
+26.37% | 4.82TCr | |
-1.01% | 4.17TCr | |
+44.02% | 4.1TCr | |
-5.31% | 2.88TCr | |
+9.34% | 2.56TCr | |
-21.69% | 1.9TCr | |
+6.23% | 1.29TCr | |
+26.99% | 1.2TCr | |
-3.38% | 1.18TCr |
- Stock Market
- Equities
- RCUS Stock
- News Arcus Biosciences, Inc.
- Mizuho Adjusts Arcus Biosciences' Price Target to $42 From $51, Keeps Buy Rating